The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis

BACKGROUND: Vortioxetine is the first mixed serotonin agonist and antagonist antidepressant approved in the US. We sought to evaluate all published and unpublished data available to determine the efficacy and harms of vortioxetine in adults with major depressive disorder. METHODS: We used a predefin...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Syst Rev
Päätekijät: Meeker, Amanda S, Herink, Megan C, Haxby, Dean G, Hartung, Daniel M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2015
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351824/
https://ncbi.nlm.nih.gov/pubmed/25874839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-015-0001-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia